Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain
Source: Acta Psychiatrica Scandinavica, Volume 114, Supplement 432, December 2006 , pp. 29-38(10)
Abstract:Gutierrez-Recacha P, Chisholm D, Haro JM, Salvador-Carulla L, Ayuso-Mateos JL. Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in spain. Objective: To estimate the cost-effectiveness of interventions for reducing the burden of schizophrenia in Spain. Method: The study examined the cost-effectiveness of seven different types of clinical interventions at the level of Spanish population: i) current situation; ii) older antipsychotics alone; iii) new antipsychotics alone (risperidone); iv) older antipsychotics plus psychosocial treatment; v) new antipsychotics plus psychosocial treatment; vi) older antipsychotics plus case management and psychosocial treatment; vii) new antipsychotics plus case management and psychosocial treatment. Results: Interventions based on the combination of haloperidol with psychosocial treatment or psychosocial treatment plus case management proved to be the most efficient strategies. Conclusion: The relatively modest additional cost of concurrent psychosocial treatment has significant health gains, thereby making such a combined strategy for schizophrenia more cost-effective than pharmacology alone.
Document Type: Research article
Affiliations: 1: Department of Psychiatry, Hospital Universitario de la Princesa, Autónoma University, Madrid, Spain 2: Department of Health System Financing, and Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland 3: Fundaciò Sant Joan de Déu; Sant Joan de Deu-SSM; Sant Boi de Llobregat, Barcelona 4: Department of Psychiatry, University of Cadiz, Cadiz, Spain
Publication date: 2006-12-01